Search
Unlocking Human Insight with Organoid Models

Unlocking Human Insight with Organoid Models

Lambda Biologics empowers innovation across life sciences – including pharma, food, cosmetics, and more – through advanced organoid technology that drives ethical, human-relevant research.

Our Services

Lambda Biologics delivers advanced in vitro solutions through organoid-based assays, research models, and technical support—enabling high-precision, animal-free testing for drug discovery and disease modeling.

Organoid Service

Specialized organoid-based assays for modeling human biology in vitro—designed to enhance predictive accuracy in drug response, toxicity, and disease progression.

Research Service

Custom in vitro studies leveraging organoid and cell-based models to support hypothesis-driven research, mechanistic validation, and translational insights.

Technical Service

Advanced analytical support including molecular profiling, spatial biology, and imaging—enabling precise characterization of organoid and cell-based systems.

Organoid - Future of Biotech

Organoids provide an ethical, reliable alternative for precision testing and efficacy evaluation. Aligned with the FDA’s New Approach Methodologies (NAMs), they offer key insights into disease modeling and therapeutic responses, accelerating safer, more effective treatments. At Lambda Biologics, organoids are the foundation of our cutting-edge research.

We Are Now On
Aug. 17~21, 2025
Washington, D.C., USA
Join us at ACS Fall 2025 in Washington, D.C. We’re excited to showcase the latest advancements in our Organoid-based platforms and explore new collaboration opportunities with researchers, innovators, and industry partners.
Aug. 26~28, 2025
South Korea
Meet us at Vitafoods Hi Korea, where we’ll be showcasing our latest innovations in health and nutrition. We look forward to connecting with partners and sharing how our ODISEI-Gut platform supports smarter, science-driven product development.
Nov. 05~09, 2025
Maryland, USA
Visit us at SITC 2025 as we present how our platform accelerates immunotherapy research through smarter experimental design and seamless collaboration. Let’s explore new ways to drive impact in cancer treatment together.

How MyLab accelerates your research?

Powered by in vitro pioneers, these cutting‑edge features transform lab wisdom into effortless workflows – experience research, reimagined.

Experimental Design Consultancy

Get tailored project guidance directly from Lambda’s experts through MyLab — real-time, personalized, and built into your workflow.

Organoid Banking System

Access a curated library of high-quality, ready-to-use organoids – standardized, scalable, and optimized to power your in vitro research.

Lambda Cloud

Securely store, access, and analyze your experimental data on MyLab — with built-in tools for seamless collaboration and smart insights.

Organoids — and Beyond

As a company specialized in organoids, we provide high-quality, customized solutions and support a differentiated one-stop service from production to delivery and post-management.

News & Insights

Organoids
Samsung Biologics
Lambda Biologics

Conferences

Explore upcoming conferences where Lambda Biologics and our partners are presenting, collaborating, and pushing the boundaries of biotech and organoid research.

ACS Fall 2025

Aug. 17~21, 2025 Washington, D.C., USA

Vitafood hi-Korea

Aug. 26~28, 2025 South Korea

SITC 2025

Nov. 05~09, 2025 Maryland, USA

Trusted by Leading Innovators

Customer insight

Advancing K-Beauty with Skin Organoids: A Next-Generation Platform for Non-Animal Testing and High-Precision Cosmetic Innovation

With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have been adopted. However, many of these approaches have limitations in replicating the complexity of human skin physiology. The emergence of skin organoids has provided a breakthrough, enabling more accurate and diverse efficacy evaluations, particularly in areas such as hair growth,...

Read full feedback
Professor Lee Chang-seok Eulji University
Customer insight

HT-X1: A Label-Free Imaging Breakthrough for Organoid-Based Disease Modeling and Drug Screening

Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without the need for any labeling, offering a clear advantage in live-cell imaging. To validate this capability, we conducted an organoid-based analysis using intestinal organoids. Among various organoid types, intestinal organoids are known to closely replicate the functional structure of the...

Read full feedback
Tomocube (Spatial)
Customer insight

Pioneering Spatial Protein Analysis in Korea: Advancing Clinical Pathology with Lambda Biologics’ Support

Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but also the spatial distribution, density, and proximity between proteins. While this approach is already widely adopted in international research, it remains relatively underutilized in Korea, making it challenging to apply in domestic studies. Thanks to Lambda Biologics, which became the...

Read full feedback
Seoul National University College of Medicine
Customer insight

ODISEI-Gut Platform Reveals Immune-Boosting Potential of Kimchi-Derived Bacterial Strain

Among the many fermented foods we consume, kimchi is particularly known for containing a diverse range of lactic acid bacteria, which are believed to influence the activation of immune cells in the body. In our research institute, we successfully isolated a bacterial strain that appears to enhance immune cell function. To evaluate its effect in the intestinal environment, we utilized the ODISEI-Gut platform. Using this platform, we investigated how the...

Read full feedback
K Research Institute
Customer insight

Multiplex Marker Analysis Enhances Research Efficiency with 31-Marker Detection on a Single Slide

We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of clinical samples posed a consistent challenge. By utilizing Lambda Biologics’ Multiplex Marker Analysis service, we were able to detect the expression of 31 markers on a single slide, enabling more comprehensive analysis while conserving precious tissue samples. This significantly enhanced...

Read full feedback
Bundang Jesaeng General Hospital
Customer insight

From Limitations to Innovation: Redefining Gastric Cancer Research with Patient-Derived Organoids

Gastric cancer is one of the leading causes of cancer-related mortality worldwide. It is a malignant solid tumor characterized by poor prognosis due to difficulties in early diagnosis and its rapid progression. Unlike many other solid tumors that primarily metastasize via lymphatic or hematogenous routes, gastric cancer most commonly spreads through the peritoneum. Peritoneal metastasis is associated with particularly poor outcomes and marked resistance to treatment, highlighting the urgent need...

Read full feedback
SOON CHUN HYANG UNIVERSITY HOSPITAL
Customer insight

Establishing Patient-Derived Breast Cancer Organoids to Accelerate TNBC Drug Development

Breast cancer is one of the most commonly diagnosed cancers among women worldwide. It is a complex and heterogeneous disease, with its progression and treatment response varying significantly depending on factors such as hormone receptor status, HER2 expression, and genetic background. Breast cancer is typically classified based on the expression of three major biomarkers: estrogen receptors (ER), progesterone receptors (PR), and HER2. Among these, tumors that do not express any...

Read full feedback
GANGNAM SEVERANCE HOSPITAL
Customer insight

Transforming Gastric Cancer Treatment: Lambda Biologics’ Patient-Derived Organoid Platform

Gastric cancer is one of the leading causes of cancer-related mortality worldwide. It is a malignant solid tumor characterized by poor prognosis due to difficulties in early diagnosis and its rapid progression. Unlike many other solid tumors that primarily metastasize via lymphatic or hematogenous routes, gastric cancer most commonly spreads through the peritoneum. Peritoneal metastasis is associated with particularly poor outcomes and marked resistance to treatment, highlighting the urgent need...

Read full feedback
SOON CHUN HYANG UNIVERSITY HOSPITAL
Customer insight

Breaking Barriers: A Novel Drug Proven to Penetrate the Tumor Microenvironment

Our newly developed drug differs from previously known therapeutics in that it directly penetrates various tumor tissues to exert its efficacy. Therefore, it was essential to analyze the drug’s penetration within the tumor microenvironment. To evaluate this, we conducted permeability testing in a co-culture system of tumor organoids and cancer-associated fibroblasts (CAF). This approach allowed us to determine the optimal drug concentration required for effective therapeutic action. As a result,...

Read full feedback
Autotelic bio
Customer insight

A New Era in Anaerobic Microbe Testing: Unlocking Functional Evaluation with the ODISEI Organoid Platform

We have been developing products utilizing various bacterial strains and have explored multiple methods to evaluate the efficacy of our developed strains. However, due to the nature of obligate anaerobic bacteria, there were significant limitations in applying conventional in vitro efficacy evaluation methods. To overcome these challenges, we explored different testing approaches and discovered the ODISEI platform. Through this platform, we confirmed that organoids enable the effective analysis of obligate...

Read full feedback
Chong Kun Dang - better life through better medicine

Connect with Us